Searchable abstracts of presentations at key conferences in endocrinology

ea0011p735 | Steroids | ECE2006

Prevalence of classical forms of 21-hydroxylase deficiency in Western Siberia according to the results of neonatal screening of congenital adrenal hyperplasia

Suplotova LA , Hramova EB , Makarova OB , Yuzakova NU , Barcova TV

The purpose: to study prevalence of classical forms of 21-hydroxylasae deficiency according to the results of neonatal screening on a congenital adrenal hyperplasia (CAH) in Tyumen, Russia.The analysis of neonatal screening on CAH results in Tyumen for the period of 2003–2004. For the period under research 20011 newborn have been tested on the 17-OHP level. Measurement of 17-hydroxyprogesterone in blood samples was done in the central laboratory by ...

ea0067o7 | Oral Presentations | EYES2019

Coexistence of medullary carcinoma and papillary carcinoma of the thyroid in a 35 year old patient with RET protooncogene mutation

Nuţu Flavia Giselle , Duşceac Roxana , Poiană Cătălina

Background: Medullary and papillary thyroid carcinomas are distinct entities, regarding their incidence, cellular and genetic origin, histopathological features and prognosis, but there have been described a few cases of the two occurring simultaneously in the same patient. Medullary thyroid carcinoma represents between 1–5% of all thyroid malignancies and it is responsible for 12–13% of all cancer related deaths. The familial form (10–20% of the cases) is cause...

ea0070aep675 | Pituitary and Neuroendocrinology | ECE2020

Gender dimorphism of intramuscular fatty infiltration and related muscle dysfunction in patients with long-term control of acromegaly

Martel-Duguech Luciana , Alonso-Pérez Jorge , Bascuñana Helena , Diaz-Manera Jordi , Alonso-Jimenez Alicia , Llauger Jaume , Nuñez-Peralta Claudia , Montesinos Paula , Webb Susan M. , Valassi Elena

Background: Muscle weakness persists in patients with acromegaly (ACRO) even long-term after disease control. Mechanisms determining this sustained impairment are not known. We hypothesized that alteration of muscle architecture, due to intramuscular fatty infiltration, is associated with muscle dysfunction in these patients.Patients and Methods: Thirty-seven acromegalic patients [21 females and 16 males, mean (± s.d.)age, 53 ± 9 years...

ea0011p809 | Thyroid | ECE2006

Study of the prevalence and mechanisms of action of TSH receptor and Gs protein alfa-subunit mutations, in toxic multinodular goiter and toxic adenoma from Galicia (Spain)

Palos F , Perez O , Alvarez-Iglesias V , Cameselle J , Barreiro F , Araujo D , Argueso R , Botana M , Cabezas JM , Dominguez L , Martinez T , Nuño J , Rueda JC , Lado-Abeal J

Toxic adenomas (TA) and toxic multinodular goiters (TMNG) are frequent causes of hyperthyroidism in Galicia, an endemic goiter area. In some European countries, 40–80% of toxic goiters are caused by TSH receptor (TSHr) and Gs alfa-subunit (Gsa) mutations that activate cAMP pathway.Aims: To study 1) the prevalence of TSHr and Gsa mutations in TMNG and TA from Galicia, 2) the clonality of sequenced samples, 3) the constitutive activity of the identifi...

ea0073aep677 | Thyroid | ECE2021

Importance in monitoring and treatment of thyroid cancer with new third-generation thyroglobulin assays

Lopez-Martos Aurora , Miguel-Angel Ruiz-Gines , Elena De-Rafael-Gonzalez , Fuentes-Bullejos Patricia , Fernando Sanchez-Escribano-Del-Palacio , Elena Valera-Nuñez , Maria-Carmen Lorenzo-Lozano , Agudo-Macazaga Mercedes

IntroductionUp by 30% of patients have recurrence in the first years after treatment of differentiated thyroid cancer (DTC) so it is necessary to have highly sensitive assays that allow adequate long-term follow-up. Nowadays, the measurement of serum thyroglobulin (Tg) is used as a tumor marker to monitoring DTC and must be determined along with levels of antithyroglobulin antibodies, since they can interfere in Tg immunoassays. Therefore, it is recommen...

ea0070aep331 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Clinical and metabolic benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) therapy in diabetic patients with psychiatric comorbidities

Concepción Terroba-Larumbe María , Crespo-Soto Cristina , Palacio-Mures Jose Maria , Gonzalez-Sagrado Manuel , Conde-Vicente Rosa , Ventosa-Viña Marta , Peña-Lozano Silvia , Portela-Martin Ainara , Fernandez-Nuñez Marta , Calleja-Barnada Mar , Cuellar-Olmedo Luis

Introduction: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) therapyhas proven effective in type 2 diabetes but there is little data on its effect in patients with psychiatric comorbidity, who usually present worse metabolic and clinical control. The aim of this study was to evaluate if there are differences in the effect of this therapy in relation to the presence of these pathologies.Methods: 225 patients included in a therapy protocol with SGLT2i,...